IntelGenx Technologies (IGX) Set to Announce Earnings on Thursday

IntelGenx Technologies (CVE:IGX) is set to announce its earnings results after the market closes on Thursday, May 9th. Analysts expect the company to announce earnings of C($0.03) per share for the quarter.

IntelGenx Technologies (CVE:IGX) last posted its quarterly earnings data on Friday, March 22nd. The company reported C($0.04) earnings per share for the quarter. The firm had revenue of C$0.86 million for the quarter, compared to the consensus estimate of C$0.26 million.

CVE IGX opened at C$0.72 on Wednesday. The company has a market cap of $65.47 million and a PE ratio of -5.29. The company has a debt-to-equity ratio of 79.62, a current ratio of 4.80 and a quick ratio of 4.49. IntelGenx Technologies has a 1-year low of C$0.60 and a 1-year high of C$2.36.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at

About IntelGenx Technologies

IntelGenx Technologies Corp., a drug delivery company, focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers RIZAPORT, an oral thin film formulation of rizatriptan benzoate for the treatment of acute migraines. The company's products under development comprise INT0001/2004, an anti-hypertension drug; INT0004/2006, an antidepressant; INT0007/2006 for the treatment of erectile dysfunction; INT0008/2007 for migraine; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid dependence; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease.

Featured Story: Range Trading

Earnings History for IntelGenx Technologies (CVE:IGX)

Receive News & Ratings for IntelGenx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies and related companies with's FREE daily email newsletter.